We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 376 results
  1. Age- and gender-specific acute poisoning with drugs and medications affecting nervous system

    Background

    We investigated acute poisonings resulting from medications affecting the nervous system and illicit substances at Loghman Hakim Hospital...

    Bita Mesgarpour, Shabnam Faridfar, ... Mohammad Abdollahi in BMC Pharmacology and Toxicology
    Article Open access 01 July 2024
  2. Screening Methods for the Evaluation of Antiparkinsonian Drugs

    Damage to dopaminergic neurons in the substantia nigra is well-established pathophysiology of Parkinson’s Disease (PD); hence, drugs targeting...
    Chapter 2022
  3. Chemical constituents, pharmacological activities, and uses of common ayurvedic medicinal plants: a future source of new drugs

    Natural products, especially plants and herbs, have always been a common medicament source, either as pure active principles or traditional...

    Parul Kaushik, Priyanka Ahlawat, ... Raman Singh in Advances in Traditional Medicine
    Article 23 November 2021
  4. Comparison of the Antiparkinson Activity of Levodopa, Memantine, and Guanidine-Containing Analogs of Amantadine and Memantine (IEM-2151 and IEM-2163) in Rats with Rotenone-Induced Parkinsonism

    Rotenone-induced parkinsonism in rats is a widely used animal model of parkinsonism for studies of the antiparkinsonism activity of new substances....

    V. E. Gmiro, S. E. Serdyuk, O. S. Veselkina in Neuroscience and Behavioral Physiology
    Article 26 April 2019
  5. Data Integration Applications in Medical Information Systems

    Medical information systems play a vital role in the everyday successful treatment of patients in hospitals, general practitioners’ offices, and...
    Marcel Friedrichs in Integrative Bioinformatics
    Chapter 2022
  6. Recent trends of bioconjugated nanomedicines through nose-to-brain delivery for neurological disorders

    The global burden of neurological disorders has been increasing day by day which calls for immediate attention to the solutions. Novel drug delivery...

    Tejas Girish Agnihotri, Govinda Shivaji Jadhav, ... Aakanchha Jain in Drug Delivery and Translational Research
    Article 15 May 2022
  7. An Insight into Herb Interactions: Clinical Evidence-Based Overview

    Medicines are used for betterment of human health, and huge number of human population uses medicines for the same. But the desired effects of these...
    Namdeo Ajay Gajanan, Bandekar Sparsha Suresh in Evidence Based Validation of Traditional Medicines
    Chapter 2021
  8. Monoamine Oxidases and Their Inhibitors

    Moussa B. H. Youdim, Keith F. Tipton in Encyclopedia of Molecular Pharmacology
    Reference work entry 2021
  9. Pharmacogenomics in Drug Metabolism Enzymes and Transporters

    The safe and effective use of drug therapies play a critical role in treating disease. Interindividual variability in drug metabolism and transport...
    Living reference work entry 2023
  10. Antiparkinsonian activity of Cucurbita pepo seeds along with possible underlying mechanism

    Cucurbita pepo is used as a vegetable in Pakistan and its seeds are also rich in tocopherol. Data showed the pivotal role of tocopherol in the...

    Uzma Saleem, Aisha Shehzad, ... Bashir Ahmad in Metabolic Brain Disease
    Article 24 March 2021
  11. Novel isoxazole derivatives as potential antiparkinson agents: synthesis, evaluation of monoamine oxidase inhibitory activity and docking studies

    Selective monoamine oxidase B inhibitors are potential drug candidates for the treatment of Parkinson’s disease. A series of phenyl substituted...

    Neetu Agrawal, Pradeep Mishra in Medicinal Chemistry Research
    Article 01 July 2019
  12. Pharmacogenomics of Alzheimer’s Disease: Novel Strategies for Drug Utilization and Development

    Alzheimer’s disease (AD) is a priority health problem in developed countries with a high cost to society. Approximately 20% of direct costs are...
    Ramón Cacabelos, Vinogran Naidoo, ... Juan C. Carril in Pharmacogenomics in Drug Discovery and Development
    Protocol 2022
  13. Orientin Modulates Nrf2-ARE, PI3K/Akt, JNK-ERK1/2, and TLR4/NF-kB Pathways to Produce Neuroprotective Benefits in Parkinson's Disease

    Parkinson's disease (PD) is characterized by oxidative stress and neuroinflammation as key pathological features. Emerging evidence suggests that...

    Deepak Vasudevan Sa**i, Praveen Thaggikuppe Krishnamurthy, ... Ravi Naik Mudavath in Neurochemical Research
    Article 26 January 2024
  14. Effect of number of medications and use of potentially inappropriate medications on frailty among early-stage older outpatients

    Background

    Frailty is an urgent concern among an aging population worldwide. However, the relationship between frailty and number and types of...

    Yuya Uragami, Kazuhiro Takikawa, ... Naomi Iihara in Journal of Pharmaceutical Health Care and Sciences
    Article Open access 03 May 2021
  15. Efficacy of low-dose risperidone in combination with sertraline in first-episode drug-naïve patients with schizophrenia: a randomized controlled open-label study

    Objective

    Despite advances in pharmacology, the treatment of schizophrenia (SZ) remains a challenge due to relapse after antipsychotic discontinuation...

    **aoe Lang, Mei Xue, ... **angyang Zhang in Journal of Translational Medicine
    Article Open access 04 July 2023
  16. Implementing in vitro and in silico approaches to evaluate anti-influenza virus activity of different Bangladeshi plant extracts

    Emergence of antiviral drug resistance in influenza virus remains a major public health concern worldwide. Nowadays, different herbs receive renewed...

    Md Abu Sayem Khan, Rifat Parveen, ... Sabita Rezwana Rahman in Advances in Traditional Medicine
    Article 27 October 2022
  17. Dexpramipexole Enhances K+ Currents and Inhibits Cell Excitability in the Rat Hippocampus In Vitro

    Dexpramipexole (DEX) has been described as the first-in-class F1Fo ATP synthase activator able to boost mitochondrial bioenergetics and provide...

    Elisabetta Coppi, Daniela Buonvicino, ... Alberto Chiarugi in Molecular Neurobiology
    Article 10 February 2021
  18. Monoamine Oxidases and Their Inhibitors

    Moussa B. H. Youdim, Keith F. Tipton in Encyclopedia of Molecular Pharmacology
    Living reference work entry 2020
  19. Prognostic biomarkers of Parkinson’s disease in the Spanish EPIC cohort: a multiplatform metabolomics approach

    The lack of knowledge about the onset and progression of Parkinson’s disease (PD) hampers its early diagnosis and treatment. Metabolomics might shed...

    Carolina Gonzalez-Riano, Jorge Saiz, ... Pilar Amiano in npj Parkinson's Disease
    Article Open access 16 August 2021
Did you find what you were looking for? Share feedback.